UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ly6e expression is restricted to syncytiotrophoblast cells of the mouse placenta

Placenta (Eastbourne), 2013-09, Vol.34 (9), p.831-835

2013

Volltextzugriff (PDF)

Phase III Trial of Vandetanib Compared With Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2011-03, Vol.29 (8), p.1059-1066

2011

Volltextzugriff (PDF)

Efficient Training for Positive Unlabeled Learning

IEEE transactions on pattern analysis and machine intelligence, 2019-11, Vol.41 (11), p.2584-2598

2019

Volltextzugriff (PDF)

Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2

Journal of clinical oncology, 2004-03, Vol.22 (5), p.785-794

2004

Volltextzugriff (PDF)

Clinicopathologic Features of Advanced Squamous NSCLC

Journal of thoracic oncology, 2016-09, Vol.11 (9), p.1411-1422

2016

Volltextzugriff (PDF)

Surgical Factors Influence Bladder Cancer Outcomes: A Cooperative Group Report

Journal of clinical oncology, 2004-07, Vol.22 (14), p.2781-2789

2004

Volltextzugriff (PDF)

Multicenter Phase II Study of the Oral MEK Inhibitor, CI-1040, in Patients With Advanced Non-Small-Cell Lung, Breast, Colon, and Pancreatic Cancer

Journal of clinical oncology, 2004-11, Vol.22 (22), p.4456-4462

2004

Volltextzugriff (PDF)

Phase I Clinical Study of Pertuzumab, a Novel HER Dimerization Inhibitor, in Patients With Advanced Cancer

Journal of clinical oncology, 2005-04, Vol.23 (11), p.2534-2543

2005

Volltextzugriff (PDF)

Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1

Journal of clinical oncology, 2004-03, Vol.22 (5), p.777-784

2004

Volltextzugriff (PDF)

Vandetanib Versus Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer: Results From a Two-Part, Double-Blind, Randomized Phase II Study

Journal of clinical oncology, 2009-05, Vol.27 (15), p.2523-2529

2009

Volltextzugriff (PDF)

Expression of aldehyde dehydrogenase family 1, member A3 in glycogen trophoblast cells of the murine placenta

Placenta (Eastbourne), 2015-03, Vol.36 (3), p.304-311

2015

Volltextzugriff (PDF)

Morphological Filter Detector for Image Forensics Applications

IEEE access, 2020, Vol.8, p.13549-13560

2020

Volltextzugriff (PDF)

A Stochastic Approach to Image Retrieval Using Relevance Feedback and Particle Swarm Optimization

IEEE transactions on multimedia, 2010-06, Vol.12 (4), p.267-277

2010

Volltextzugriff (PDF)

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial

JAMA : the journal of the American Medical Association, 2003-10, Vol.290 (16), p.2149

2003

Volltextzugriff (PDF)

Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer

The New England journal of medicine, 2003-08, Vol.349 (9), p.859-866

2003

Volltextzugriff (PDF)

Baseline Vascular Endothelial Growth Factor Concentration as a Potential Predictive Marker of Benefit from Vandetanib in Non–Small Cell Lung Cancer

Clinical cancer research, 2009-05, Vol.15 (10), p.3600-3609

2009

Volltextzugriff (PDF)

Osimertinib in Patients With Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer and Leptomeningeal Metastases: The BLOOM Study

Journal of clinical oncology, 2020-02, Vol.38 (6), p.538-547

2020

Volltextzugriff (PDF)

Fast automatic camera network calibration through human mesh recovery

Journal of real-time image processing, 2020-12, Vol.17 (6), p.1757-1768

2020

Volltextzugriff (PDF)

A Deterministic Approach to Detect Median Filtering in 1D Data

IEEE transactions on information forensics and security, 2016-07, Vol.11 (7), p.1425-1437

2016

Volltextzugriff (PDF)

Randomized phase III trial comparing cisplatin–etoposide to carboplatin–paclitaxel in advanced or metastatic non-small cell lung cancer

Annals of oncology, 2005-07, Vol.16 (7), p.1069-1075

2005

Volltextzugriff (PDF)

Clinically Meaningful Improvement in Symptoms and Quality of Life for Patients With Non-Small-Cell Lung Cancer Receiving Gefitinib in a Randomized Controlled Trial

Journal of clinical oncology, 2005-05, Vol.23 (13), p.2946-2954

2005

Volltextzugriff (PDF)

Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer's disease and frontotemporal lobar degeneration

Dementia and geriatric cognitive disorders, 2010-01, Vol.29 (5), p.448-456

2010

Volltextzugriff (PDF)

Current and Emergent Therapy Options for Advanced Squamous Cell Lung Cancer

Journal of thoracic oncology, 2018-02, Vol.13 (2), p.165-183

2018

Volltextzugriff (PDF)

Epithelial Membrane Protein-1 Is a Biomarker of Gefitinib Resistance

Proceedings of the National Academy of Sciences - PNAS, 2005-08, Vol.102 (33), p.11858-11863

2005

Volltextzugriff (PDF)

Efficacy and Safety of Single-Agent Pertuzumab, a Human Epidermal Receptor Dimerization Inhibitor, in Patients with Non–Small Cell Lung Cancer

Clinical cancer research, 2007-10, Vol.13 (20), p.6175-6181

2007

Volltextzugriff (PDF)

1 – 25 von 1.472

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.101)
Mit Volltextzugriff
(1.210)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(951)
Life Sciences & Biomedicine
(549)
Humans
(528)
Female
(331)
Technology
(321)
Male
(310)
Engineering
(252)
Engineering, Electrical & Electronic
(227)
Biological And Medical Sciences
(210)
Middle Aged
(208)
Medical Sciences
(186)
Aged
(173)
Adult
(165)
Physical Sciences
(134)
Oncology
(123)
Cardiovascular System & Cardiology
(112)
Cardiac & Cardiovascular Systems
(109)
Animals
(86)
Treatment Outcome
(84)
Child
(72)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(61)
Europace
(31)
Heart Rhythm
(23)
Cancer
(19)
European Heart Journal
(19)
American Journal Of Obstetrics And Gynecology
(18)
Journal Of Cardiovascular Electrophysiology
(18)
Jacc. Clinical Electrophysiology
(17)
Annals Of Oncology
(14)
Seminars In Oncology
(14)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Ly6e expression is restricted to syncytiotrophoblast cells of the mouse placenta

Phase III Trial of Vandetanib Compared With Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer

Efficient Training for Positive Unlabeled Learning

Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2

Clinicopathologic Features of Advanced Squamous NSCLC

Surgical Factors Influence Bladder Cancer Outcomes: A Cooperative Group Report

Multicenter Phase II Study of the Oral MEK Inhibitor, CI-1040, in Patients With Advanced Non-Small-Cell Lung, Breast, Colon, and Pancreatic Cancer

Phase I Clinical Study of Pertuzumab, a Novel HER Dimerization Inhibitor, in Patients With Advanced Cancer

Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1

Vandetanib Versus Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer: Results From a Two-Part, Double-Blind, Randomized Phase II Study

Expression of aldehyde dehydrogenase family 1, member A3 in glycogen trophoblast cells of the murine placenta

Morphological Filter Detector for Image Forensics Applications

A Stochastic Approach to Image Retrieval Using Relevance Feedback and Particle Swarm Optimization

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial

Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer

Baseline Vascular Endothelial Growth Factor Concentration as a Potential Predictive Marker of Benefit from Vandetanib in Non–Small Cell Lung Cancer

Osimertinib in Patients With Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer and Leptomeningeal Metastases: The BLOOM Study

Fast automatic camera network calibration through human mesh recovery

A Deterministic Approach to Detect Median Filtering in 1D Data

Randomized phase III trial comparing cisplatin–etoposide to carboplatin–paclitaxel in advanced or metastatic non-small cell lung cancer

Clinically Meaningful Improvement in Symptoms and Quality of Life for Patients With Non-Small-Cell Lung Cancer Receiving Gefitinib in a Randomized Controlled Trial

Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer's disease and frontotemporal lobar degeneration

Current and Emergent Therapy Options for Advanced Squamous Cell Lung Cancer

Epithelial Membrane Protein-1 Is a Biomarker of Gefitinib Resistance

Efficacy and Safety of Single-Agent Pertuzumab, a Human Epidermal Receptor Dimerization Inhibitor, in Patients with Non–Small Cell Lung Cancer

Suchergebnisse filtern